Hepatitis C is treated by several types of doctors, and the right one for you depends largely on how advanced the infection is. Most people with uncomplicated hepatitis C can be treated by a primary care provider. Those with liver damage, prior treatment failure, or other complications are typically referred to a specialist such as a gastroenterologist, hepatologist, or infectious disease physician.
Primary Care Providers Treat Most Cases
The landscape of hepatitis C treatment shifted dramatically with the introduction of direct-acting antiviral medications, which cure the infection in the vast majority of people. These regimens are straightforward enough that primary care doctors, nurse practitioners, and physician assistants can manage them for patients who have never been treated before and who have no significant liver scarring. Joint guidelines from the American Association for the Study of Liver Diseases and the Infectious Diseases Society of America specifically support this expanded role, noting that simplified treatment algorithms reduce the amount of pretreatment workup and monitoring a clinician needs to perform.
The practical benefit is significant. Expanding treatment beyond specialists means shorter wait times, lower costs, and fewer appointments at distant medical centers. In many clinics, a nurse practitioner handles the entire course of treatment, from ordering labs to managing follow-up visits. For straightforward cases, the experience is simple: a confirmed diagnosis, a course of pills lasting 8 to 12 weeks, and blood work afterward to confirm the virus is gone.
When You Need a Specialist
Not every case of hepatitis C is straightforward. If you have cirrhosis (significant scarring of the liver), especially decompensated cirrhosis where the liver is struggling to function, your primary care provider will refer you to a gastroenterologist or hepatologist. The same applies if you’ve already completed a course of antiviral treatment and the virus came back. These situations require closer monitoring, potentially different medication combinations, and ongoing surveillance for liver cancer.
A gastroenterologist is a doctor who specializes in the entire digestive system, including the liver. A hepatologist is a gastroenterologist with additional, narrower training focused specifically on liver disease. Either can manage complex hepatitis C, and in practice the distinction matters less than their experience with advanced liver disease. If your liver damage is severe enough that transplantation might be necessary, treatment should happen at a center with transplant expertise.
Infectious Disease Specialists
Infectious disease doctors are another common pathway into hepatitis C care, particularly if you also have HIV or another coinfection. These physicians specialize in viral infections broadly and are well equipped to coordinate treatment when multiple infections need to be managed simultaneously. In many hospitals and health systems, hepatitis C care is split between gastroenterology and infectious disease departments, and either route leads to effective treatment.
How Diagnosis Typically Works
Screening usually starts with your primary care provider or at a community health clinic. The CDC recommends that all adults be tested at least once in their lifetime. The process involves two steps, ideally completed from a single blood draw. First, an antibody test checks whether you’ve ever been exposed to the virus. If that comes back positive, a second test looks for active viral genetic material in your blood. A positive result on both confirms a current infection that needs treatment. Many labs now run the second test automatically when the antibody result is positive, which eliminates the need for a return visit just to confirm the diagnosis.
Once diagnosed, your provider will assess the health of your liver, typically through blood tests or a specialized imaging scan that measures liver stiffness. This is the key step that determines whether you can be treated in primary care or need a referral. If the results show minimal scarring, treatment can proceed right where you are.
Treatment Access in Rural and Underserved Areas
One of the biggest barriers to hepatitis C treatment has been geography. Specialists cluster in cities, and people in rural communities, on tribal lands, or in correctional facilities often face long wait times or travel distances that make specialist visits impractical. A program called Project ECHO, developed at the University of New Mexico, addressed this by connecting primary care providers in remote clinics and prisons with university specialists through weekly telemedicine sessions. During these sessions, local clinicians present their hepatitis C patients and get real-time guidance from gastroenterologists, infectious disease doctors, psychiatrists, and pharmacologists.
The model works. Primary care providers who participate develop enough expertise over time that they need less and less specialist support, while their patients get treated locally instead of waiting months for a referral. Similar telemedicine-supported models have since expanded to other states, making it possible for people in underserved areas to receive the same quality of care available at academic medical centers.
Choosing the Right Provider for You
If you’ve just been diagnosed, start with whoever diagnosed you. A primary care provider who is comfortable prescribing antiviral therapy can handle your treatment from start to finish if your liver is in reasonable shape. If they’re not experienced with hepatitis C treatment, they should refer you, and any of the three specialist types (gastroenterologist, hepatologist, or infectious disease physician) can take it from there.
The factors that push toward specialist care are liver damage, previous treatment that didn’t work, kidney disease, a history of liver transplant, or coinfection with HIV or hepatitis B. If none of those apply to you, the most important thing isn’t the type of doctor on your chart. It’s that someone prescribes the antiviral course and follows up to confirm the virus has cleared. With current medications, cure rates exceed 95% regardless of which provider manages the treatment.